*** For details on how to be removed from this list visit the *** *** CCP4 home page http://www.ccp4.ac.uk ***
Sorry, yes I should have said that I'm looking at the latest (5th) Ed. (2002) of Vol. A. Peter Brick reports that this section is not in earlier eds of Vol. A, so don't go buying second-hand copies from eBay without asking searching questions! -- Ian > -----Original Message----- > From: [EMAIL PROTECTED] [mailto:[EMAIL PROTECTED] On > Behalf Of Simon Kolstoe > Sent: Tuesday, September 12, 2006 3:44 PM > To: [email protected] > Subject: Re: [ccp4bb]: Index conventions > > *** For details on how to be removed from this list visit the *** > *** CCP4 home page http://www.ccp4.ac.uk *** > > > At last, ammunition to convince my boss to buy a more up to > date version > of international tables. He is convinced that the 1969 version still > tells us everything we need to know - seems section 9 was written > sometime within the last 37 years! > > Thanks for the help. > > Simon > > Ian Tickle wrote: > > > > >Hi Simon > > > >It's in Vol. A, Table 9.3.4.1 'Conventional cells' (p. 758). > > > >i.e. a < b < c for oP, oI & oF (oC is a special case, see Table). > > > >The order is independent of handedness. If necessary the > direction of > >one axis is reversed to make the cell right-handed. > > > >-- Ian > > > > > > > >>-----Original Message----- > >>From: [EMAIL PROTECTED] [mailto:[EMAIL PROTECTED] On > >>Behalf Of Simon Kolstoe > >>Sent: Tuesday, September 12, 2006 2:38 PM > >>To: [email protected] > >>Subject: [ccp4bb]: Index conventions > >> > >>*** For details on how to be removed from this list visit the *** > >>*** CCP4 home page http://www.ccp4.ac.uk *** > >> > >> > >>Dear ccp4bb, > >> > >>Could anyone tell me where I can find the index conventions > regarding > >>how one specifies unit cell lengths (ie in Orthorhombic, > after taking > >>into consideration handedness, do I put the lengths in > increasing or > >>decreasing order)? I've been vaguely flicking through international > >>tables for the last couple days without much joy. > >> > >>Simon > >> > >> > >> > >> > >> > >> > > > >Disclaimer > > > >This communication is confidential and may contain > privileged information intended solely for the named > addressee(s). It may not be used or disclosed except for the > purpose for which it has been sent. If you are not the > intended recipient you must not review, use, disclose, copy, > distribute or take any action in reliance upon it. If you > have received this communication in error, please notify > Astex Therapeutics Ltd by emailing > [EMAIL PROTECTED] and destroy all copies of the > message and any attached documents. > > > > > > > >Astex Therapeutics Ltd monitors, controls and protects all > its messaging traffic in compliance with its corporate email > policy. The Company accepts no liability or responsibility > for any onward transmission or use of emails and attachments > having left the Astex Therapeutics domain. Unless expressly > stated, opinions in this message are those of the individual > sender and not of Astex Therapeutics Ltd. The recipient > should check this email and any attachments for the presence > of computer viruses. Astex Therapeutics Ltd accepts no > liability for damage caused by any virus transmitted by this > email. E-mail is susceptible to data corruption, > interception, unauthorized amendment, and tampering, Astex > Therapeutics Ltd only send and receive e-mails on the basis > that the Company is not liable for any such alteration or any > consequences thereof. > > > > > > > > > > > > > > > > > -- > Dr. Simon Kolstoe, Research Fellow > Rm 5067, School of Biological Sciences, > University of Southampton, > Southampton, SO16 7PX, UK > email: [EMAIL PROTECTED] > > > > Disclaimer This communication is confidential and may contain privileged information intended solely for the named addressee(s). It may not be used or disclosed except for the purpose for which it has been sent. If you are not the intended recipient you must not review, use, disclose, copy, distribute or take any action in reliance upon it. If you have received this communication in error, please notify Astex Therapeutics Ltd by emailing [EMAIL PROTECTED] and destroy all copies of the message and any attached documents. Astex Therapeutics Ltd monitors, controls and protects all its messaging traffic in compliance with its corporate email policy. The Company accepts no liability or responsibility for any onward transmission or use of emails and attachments having left the Astex Therapeutics domain. Unless expressly stated, opinions in this message are those of the individual sender and not of Astex Therapeutics Ltd. The recipient should check this email and any attachments for the presence of computer viruses. Astex Therapeutics Ltd accepts no liability for damage caused by any virus transmitted by this email. E-mail is susceptible to data corruption, interception, unauthorized amendment, and tampering, Astex Therapeutics Ltd only send and receive e-mails on the basis that the Company is not liable for any such alteration or any consequences thereof.
